CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies.
Blood
; 131(6): 611-620, 2018 02 08.
Article
in En
| MEDLINE
| ID: mdl-29158362
Full text:
1
Database:
MEDLINE
Main subject:
Leukemia, B-Cell
/
Lymphoma, B-Cell
/
Radioimmunotherapy
/
Antibodies, Bispecific
/
ADP-ribosyl Cyclase 1
/
Multiple Myeloma
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Blood
Year:
2018
Type:
Article